Number of pages: 100 | Report Format: PDF | Published date: May 10, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
Report Attribute |
Details |
CAGR |
4.5% |
Base Year For Estimation |
2022 |
Forecast Period |
2023 to 2031 |
Historical Year |
2021 |
Segments Covered |
Product Type, Procedure Type, End User, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global eschar removal treatment market is expected to register a revenue CAGR of 4.5% during the forecast period from 2023 to 2031.
Eschar Removal Treatment Market Fundamentals
Eschar is a dry, scab-like, or blackened tissue that forms over a wound during healing. The eschar removal is typically done by a healthcare professional and is part of wound care management. The removal of eschar helps to promote healing, prevent infection, and improve the cosmetic appearance of the wound. The treatment for eschar removal varies depending on the severity and location of the wound. In some cases, the eschar may be removed through debridement, which removes dead or damaged tissue. Debridement can be done using sharp instruments, such as a scalpel, or non-sharp methods, like enzymes or dressings. In other cases, the eschar may need to be surgically removed.
The global eschar removal treatment industry analysis report comprehensively analyzes the market, with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the Eschar Removal Treatment market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the eschar removal treatment market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
Eschar Removal Treatment Market Dynamics
The eschar removal treatment market is a part of the larger wound care market, driven by several factors. Chronic wounds, such as pressure ulcers, diabetic foot, and venous leg ulcers, are a major healthcare problem worldwide. These wounds often lead to eschar formation, and the increasing prevalence of chronic wounds is expected to drive the demand for eschar removal treatment. The global population is aging, and older adults are more prone to chronic wounds and related complications. The aging population is expected to increase the demand for eschar removal treatment. There have been several technological advancements in wound care, including developing new dressings, wound closure and debridement devices, and other products that can help remove eschar. These advancements are expected to drive the growth of the eschar removal treatment market. According to the World Health Organization (WHO), an estimated 180,000 deaths occur each year from burns, most of which occur in low- and middle-income countries.
However, some regions may have limited access to healthcare services, including wound care management. This is likely to restrict the demand for eschar removal treatment in these areas.
Eschar Removal Treatment Market Ecosystem
Eschar Removal Treatment Market, by Product Type
Eschar Removal Treatment Market, by Procedure Type
Eschar Removal Treatment Market, by End User
Eschar Removal Treatment Market by Procedure Type
[1254]
The enzymatic debridement segment accounts for a significant revenue share in the global eschar removal treatment market. Enzymatic debridement is often considered the first line of treatment for eschar removal because it is non-invasive and painless, generally safe and effective for a wide range of wounds. Enzymatic debridement involves topical agents that contain enzymes to break down the dead tissue, including eschar, in the wound.
The market segmentation sections provide the eschar removal treatment market outlook in terms of the demarcation of different consumer groups. Market segmentation is the split of an industry into subgroups depending on characteristics such as product type, procedure type, end user, and region. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential Eschar Removal Treatment market demand opportunities.
Eschar Removal Treatment Market by Region
North America accounts for the largest revenue share in the global eschar removal treatment market. Chronic wounds are a growing healthcare concern in North America, with millions of people affected each year. As the population ages, the incidence of chronic wounds is expected to increase, driving demand for eschar removal treatments. According to a report by the US Wound Registry, chronic wounds affect approximately 6.5 million people in the United States, with an estimated prevalence of 2% among adults over the age of 65. The economic burden of chronic wounds in the US is estimated to be between $28 billion and $31 billion per year. Developing new technologies for eschar removal, such as enzymatic debridement agents and advanced dressings, is also driving market growth in North America. In North America, burn injuries are a significant public health issue. According to the American Burn Association (ABA), there are approximately 450,000 burn injuries each year in the United States, with around 40,000 requiring hospitalization. The ABA reports that burn injuries are the leading cause of accidental death and injury in children under the age of 14 and the fourth leading cause of accidental death and injury in adults. Burn wounds lead to the development of eschar eventually.
The market for eschar removal treatment in the Asia Pacific region is expected to grow significantly in the coming years. The prevalence of chronic wounds, which can lead to eschar formation, is increasing in the Asia Pacific region due to aging populations, an increase in diabetes, and a rise in pressure ulcers. According to a report by the International Diabetes Federation (IDF), the prevalence of diabetes in the Asia Pacific region is increasing rapidly, with an estimated 463 million adults living with diabetes in 2019. Diabetes is a major risk factor for chronic wounds, which can lead to the formation of eschar. Developing new technologies for eschar removal, such as enzymatic debridement agents and advanced dressings, is also driving market growth in the Asia Pacific region. The eschar removal treatment market in the Asia Pacific region is highly competitive, with several established players and new entrants. The market is expected to continue to grow in the coming years, driven by the factors mentioned above.
Based on the regions, the global eschar removal treatment market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of Eschar Removal Treatment industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level eschar removal treatment market overview.
Key Components of the Report
Eschar Removal Treatment Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Eschar Removal Treatment Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Eschar removal treatment involves the removal of dead tissue or eschar from a wound to promote healing and prevent infection. Eschar is a thick, dry, black or brown scab that forms over a wound, usually because of burns or deep tissue damage.
The global eschar removal treatment is expected to grow at a revenue CAGR of 4.5% during the forecast period from 2023 to 2031.
The prevalence of chronic wounds is increasing worldwide, particularly in aging populations. This is expected to drive demand for eschar removal treatment products and services.
Eschar removal treatment can be expensive, particularly in cases where surgical debridement is required. High costs can limit patient access to treatment and reduce market growth.
Technological advances are driving the development of new and innovative eschar removal products and services, such as advanced wound dressings and mechanical debridement devices.
B. Braun Melsungen AG, Coloplast A/S, Mölnlycke Health Care AB, ConvaTec Group plc, and Zimmer Biomet Holdings, Inc. are some of the key players in the global eschar removal treatment market.
The enzymatic debridement segment accounts for the largest revenue share in the global eschar removal treatment market by procedure type.
Key players in the eschar removal treatment market continue to develop and launch new products and technologies to improve patient outcomes and gain a competitive advantage. For example, in recent years, several new enzymatic debridement products have been introduced to the market that offers faster and more effective removal of eschar.
North America will have the largest market size during the forecast period from 2023 to 2031.
*Insights on financial performance are subject to the availability of information in the public domain